| 000 | 01635 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250512075643.0 | ||
| 264 | 0 | _c19850830 | |
| 008 | 198508s 0 0 eng d | ||
| 022 | _a0008-543X | ||
| 024 | 7 |
_a10.1002/1097-0142(19850901)56:5<1006::aid-cncr2820560505>3.0.co;2-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJacobs, P | |
| 245 | 0 | 0 |
_aVP-16-213 in the treatment of stage III and IV diffuse large cell lymphoma. _h[electronic resource] |
| 260 |
_bCancer _cSep 1985 |
||
| 300 |
_a1006-13 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAlopecia _xchemically induced |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aBone Marrow _xdrug effects |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
| 650 | 0 | 4 |
_aEtoposide _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukopenia _xchemically induced |
| 650 | 0 | 4 |
_aLymphoma _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPodophyllotoxin _xanalogs & derivatives |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRandom Allocation |
| 700 | 1 | _aKing, H S | |
| 700 | 1 | _aDent, D M | |
| 700 | 1 | _aHayes, M | |
| 773 | 0 |
_tCancer _gvol. 56 _gno. 5 _gp. 1006-13 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/1097-0142(19850901)56:5<1006::aid-cncr2820560505>3.0.co;2-7 _zAvailable from publisher's website |
| 999 |
_c3899370 _d3899370 |
||